Trends in pharmaceutical targeting of clinical indications: 1930-2013

Drug Discovery Today

Volumn 19, Issue 11, 2014, Pages 1682-1685

  Kinch, Michael S ^a   Merkel, Janie ^a   Umlauf, Sheila ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

AUTOIMMUNE DISEASE; BIOTECHNOLOGY; CARDIOVASCULAR DISEASE; DRUG INDICATION; DRUG INDUSTRY; DRUG TARGETING; FOOD AND DRUG ADMINISTRATION; HUMAN; INFECTION; INFLAMMATORY DISEASE; NEOPLASM; REIMBURSEMENT; REVIEW; DRUG APPROVAL; DRUG DEVELOPMENT; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES;

DRUG APPROVAL; DRUG DISCOVERY; DRUG INDUSTRY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84910654115     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.05.021     Document Type: Short Survey

References (7)

1. M.S. Kinch An overview of FDA-approved new molecular entities: 1827-2013 Drug Discov. Today 2014 10.1016/j.drudis.2014.03.018
2. M.S. Kinch The rise (and decline?) of biotechnology Drug Discov. Today 2014 10.1016/j.drudis.2014.04.006
3. O. Wellman-Labadie, and Y. Zhou The US Orphan Drug Act: rare disease research stimulator or commercial opportunity? Health Policy 95 2010 216 228
4. National Center for Health Statistics. (2013) Health, United States, 2012: With Special Feature on Emergency Care. In: United States Department of Health & Human Services CfDCaP (National Center for Health Statistics, ed), Centers for Disease Control
5. CDC. (2014) Vital Statistics of the United States. Atlanta, GA
6. V. Hunt A wake-up call for Big Pharma McKinsey Quarterly December 2011
7. K.I. Kaitin, and J.A. DiMasi Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009 Clin. Pharmacol. Ther. 89 2011 183 188